6-Bromo-1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphthalene(CAS: 27452-17-1)

6-Bromo-1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphthalene (CAS: 27452-17-1) is regulated under the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) and specific regulations such as REACH in the European Union. It is also subject to FDA guidelines for pharmaceutical applications and EPA requirements for environmental protection and safety in the United States.

There are alternative compounds such as 6-chloro-1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphthalene and 6-fluoro-1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphthalene that can be used as substitutes in synthesis. These alternatives offer similar chemical properties and can be chosen based on the specific requirements of the reaction.

The market for 6-Bromo-1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphthalene (CAS: 27452-17-1) is driven by its use in pharmaceuticals, particularly in the development of anti-inflammatory and anti-cancer drugs. Research trends indicate an increasing focus on its application in novel drug discovery and as a precursor for synthesizing other complex molecules.

Waste containing 6-Bromo-1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphthalene (CAS: 27452-17-1) should be collected in a closed container and disposed of according to local hazardous waste regulations. It is recommended to incinerate the waste or use professional waste disposal services to ensure compliance with environmental protection standards and safety guidelines.